![]() (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol结构式
![]() |
常用名 | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol | 英文名 | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol |
---|---|---|---|---|
CAS号 | 131563-73-0 | 分子量 | 301.33700 | |
密度 | 1.54g/cm3 | 沸点 | 537.2ºC at 760mmHg | |
分子式 | C17H19NO4 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 278.7ºC | |
符号 |
![]() ![]() ![]() GHS02, GHS06, GHS08 |
信号词 | Danger |
英文名 | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol |
---|---|
英文别名 | 更多 |
密度 | 1.54g/cm3 |
---|---|
沸点 | 537.2ºC at 760mmHg |
分子式 | C17H19NO4 |
分子量 | 301.33700 |
闪点 | 278.7ºC |
精确质量 | 301.13100 |
PSA | 73.16000 |
LogP | 0.62690 |
蒸汽压 | 2.27E-12mmHg at 25°C |
折射率 | 1.747 |
符号 |
![]() ![]() ![]() GHS02, GHS06, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H225-H301 + H311 + H331-H370 |
警示性声明 | P210-P260-P280-P301 + P310-P311 |
危险品运输编码 | UN1230 - class 3 - PG 2 - Methanol, solution |
Impurities in a morphine sulfate drug product identified as 5-(hydroxymethyl)-2-furfural, 10-hydroxymorphine and 10-oxomorphine.
J. Pharm. Sci. 92(3) , 485-93, (2003) Stability testing of morphine sulfate formulated with nonpareil sugar seeds (consisting of sucrose and starch) and fumaric acid revealed the formation of the three impurities 5-(hydroxymethyl)-2-furfu... |
|
Morphine impurity with opioid activity is identified as 10 alpha-hydroxymorphine.
Pharm. Res. 7(11) , 1205-7, (1990)
|
|
Separation of morphine and its oxidation products by capillary zone electrophoresis.
J. Pharm. Biomed. Anal. 20(1-2) , 179-83, (1999) Separation of morphine and its oxidation products (10-S-hydroxymorphine, pseudomorphine and morphine N-oxide) by capillary zone electrophoresis in Tris-borate buffer in the presence of cyclodextrins w... |
10-Hydroxymorphine |